ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,860Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 229

$696K Total Retail Price of All Prescriptions

Rank: 23 out of 229

748 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 748 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

12% of this provider’s 748 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

4% of this provider’s 10,819 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 795 733 1 1
LISINOPRIL 646 564 2 2
SIMVASTATIN 483 456 3 3
HYDROCODONE-ACETAMINOPHEN 466 354 S3 4 7
OMEPRAZOLE 401 338 5 4
AMLODIPINE BESYLATE 312 295 6 5
METFORMIN HCL 289 242 7 6
LOVASTATIN 268 251 8 11
HYDROCHLOROTHIAZIDE 262 240 9 9
GABAPENTIN 221 176 10 10
ATENOLOL 193 184 11 19
FUROSEMIDE 173 139 12 8
LOSARTAN POTASSIUM 165 151 13 12
CITALOPRAM HBR 163 146 14 21
ZOLPIDEM TARTRATE 162 134 15 20
DIOVAN 153 153 16 42
METOPROLOL TARTRATE 151 125 17 13
PREMARIN 141 133 R 18 101
FLUTICASONE PROPIONATE 141 122 18 23
SERTRALINE HCL 140 101 20 22
ALENDRONATE SODIUM 124 112 21 14
ALLOPURINOL 116 100 22 27
TAMSULOSIN HCL 111 109 23 24
GEMFIBROZIL 106 102 24 62
METOPROLOL SUCCINATE 105 104 25 16
OXYCODONE HCL 104 54 S2 26 37
GLIPIZIDE 103 72 27 36
ATORVASTATIN CALCIUM 99 87 28 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 98 91 29 28
TRIAMTERENE-HCTZ 95 88 30 51
CRESTOR 94 82 31 30
BENAZEPRIL HCL 90 89 32 86
FENTANYL 88 63 S2 33 108
PAROXETINE HCL 88 85 33 49
FLUOXETINE HCL 87 67 35 41
FENOFIBRATE 87 72 35 68
CYCLOBENZAPRINE HCL 82 49 R 37 75
BACLOFEN 82 34 37 107
ESTRADIOL 82 48 R 37 138
PANTOPRAZOLE SODIUM 80 55 40 33
TRAMADOL HCL 80 71 40 26
PROAIR HFA 79 62 42 38
MORPHINE SULFATE ER 78 46 S2 43 70
DOXAZOSIN MESYLATE 77 77 44 50
OXYCODONE HCL-ACETAMINOPHEN 76 57 S2 45 73
SYNTHROID 70 65 46 46
CYMBALTA 69 57 47 64
TRAZODONE HCL 68 26 48 34
AMITRIPTYLINE HCL 63 55 R 49 66
POTASSIUM CHLORIDE 63 52 49 18
WARFARIN SODIUM 61 48 51 17
CLOPIDOGREL 60 60 52 44
PROPRANOLOL HCL 58 38 53 127
CLONIDINE HCL 55 55 54 69
OXYCODONE-ACETAMINOPHEN 52 37 S2 55 43
CEPHALEXIN 52 42 55 87
DICLOFENAC SODIUM 52 42 55 168
ACETAMINOPHEN-CODEINE 52 45 S3 55 79
METFORMIN HCL ER 51 39 59 77
DONEPEZIL HCL 51 51 59 29
CELEBREX 51 33 59 71
DILTIAZEM 24HR ER 51 44 59 237
FLUOCINONIDE 50 46 63 212
SPIRONOLACTONE 50 38 63 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 19, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.